Arginyl-Glutamine (TFA)

• Description:

  Arginyl-Glutamine TFA is a dipeptide that can decrease VEGF levels and inhibit retinal neovascularization in a mouse model of oxygen-induced retinopathy[1].

• Product Name Alternative:

  H-Arg-Gln-OH (TFA)

• UNSPSC:

  12352209

• Target:

  VEGFR

• Related Pathways:

  Protein Tyrosine Kinase/RTK

• Field of Research:

  Cardiovascular Disease

• Purity:

  99.22

• Smiles:

  N=C(N)NCCC[C@H](N)C(N[C@H](C(O)=O)CCC(N)=O)=O.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

• Molecular Formula:

  C17H25F9N6O10

• Molecular Weight:

  644.40

• References & Citations:

  [1]Neu J, et al. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2006 Jul;47 (7) :3151-5.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

• Scientific Category:

  Peptides

• Clinical Information:

  No Development Reported